article_snippet.sent: The research has been hailed a 'tour de force', raising hopes the body's immune system could be trained to attack melanoma, pancreatic, breast and lung cancer.
article_snippet.sent: Their findings have been hailed a 'tour de force', raising hopes the bodycould be trained to attack melanoma, pancreatic, lung and breast cancer, pictured .
article_snippet.sent: The team at Stanford University School of Medicine concluded The team at Stanford University School of Medicine approach differed to other potential treatments that only apply to specific cancers, in that The team at Stanford University School of Medicine could target a wide range of solid tumours.
article_snippet.sent: The team at Stanford University School of Medicine concluded The team at Stanford University School of Medicine approach differed to other potential treatments that only apply to specific cancers, in that The team at Stanford University School of Medicine could target a wide range of solid tumours, including melanoma, pictured .
article_snippet.sent: Medical oncologist assistant professor Holbrook Kohrt at Stanford, who was not involved with the study, called the paper 'a nice tour de force' and believes the novel therapeutic strategy could utilise the patient's own immune system to defend against certain cancers.
article_snippet.sent: Medical oncologist assistant professor Holbrook Kohrt at Stanford, who was not involved with the study oversees numerous clinical trials involving immunotherapy for cancer patients and thinks an important aspect of the technique is the technique potential to fight different tumour types.
article_snippet.sent: Medical oncologist assistant professor Holbrook Kohrt at Stanford, who was not involved with the study added that given the chemicals used have already been used in other clinical trials, developing the chemicals used into a therapeutic drug should be 'fairly straightforward'. '
highlights_snippet.sent: Study at Stanford University has been hailed a 'tour de force'
  Raises hopes the body's immune system could be trained to attack a range of cancers, including melanoma, pancreatic, breast and lung .
  